Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan-Reference-Cited by-同舟云学术

Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan

Published:2023-03-31 Issue:6 Volume:34 Page:1101-1109
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Kunihara Takahiro,Tohmori Hidetoshi,Tsukamoto Manabu^ORCID,Kobayashi Masashi,Okumura Toshiya,Teramoto Hidefumi,Hamasaki Takahiko,Yamasaki Takuma,Nakagawa Tsuyoshi,Okimoto Nobukazu^ORCID,Fujiwara Saeko^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-023-06732-8.pdf

Reference20 articles.

1. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg 80:920–943. https://doi.org/10.1016/j.joms.2022.02.008

2. Khan AA, Morrison A, Hanley DA et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23. https://doi.org/10.1002/jbmr.2405

3. Tamaki J, Fujimori K, Ikehara S, Kamiya K, Nakatoh S, Okimoto N, Ogawa S, Ishii S, Iki M (2019) Estimates of hip fracture incidence in Japan using the national health insurance claim database in 2012–2015. Osteoporos Int 30:975–983. https://doi.org/10.1007/s00198-019-04844-8

4. Hamasaki T, Okimoto N, Teramoto H, Shirakawa T, Nakagawa T, Mizuno N, Yamasaki T, Sasashige Y, Fujiwara S (2020) Incidence of clinical vertebral fractures and hip fractures of the elderly (65 years or over) population-large-scale data analysis using claim database in Kure City, Hiroshima. Japan Arch Osteoporos 15:124. https://doi.org/10.1007/s11657-020-00797-2

5. Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Nagata T, Urade M, Shibahara T, Toyosawa S (2017) Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw. J Bone Miner Metab 35:6–19. https://doi.org/10.1007/s00774-016-0810-7.Erratum.In:JBoneMinerMetab.2017Jan;35(1):20

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors of Medication-Related Osteonecrosis of the Jaw: A Clinical Investigation;Journal of Stomatology, Oral and Maxillofacial Surgery;2024-02

2. Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05);Journal of Bone and Mineral Metabolism;2023-10-28

3. Antiresorptiva-assoziierte Kiefernekrose – Update 2023;best practice onkologie;2023-09

4. Cooperation between physicians and dentists for osteonecrosis of the jaw: a 2022 Japanese survey;Journal of Bone and Mineral Metabolism;2023-07-30

5. Comparison of Different Antibiotic Regimes for Preventive Tooth Extractions in Patients with Antiresorptive Intake—A Retrospective Cohort Study;Antibiotics;2023-06-01